The combination of EGCG and theaflavin (TF) has also been shown to effectively downregulate Wnt signaling in hepatocellular carcinoma cells, inhibit cell proliferation, and promote apoptosis, thereby inhibiting the development of hepatocellular carcinoma [126]. Here, TF is linked to hepatocellular carcinoma.